Report on the incidence of interstitial lung diseases in Spain

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 21, Issue 1, 2004, Pages 64-70

  Xaubet, Antoni ^a   Ancochea, Julio ^b   Morell, Ferran ^c   Rodriguez Arias, José Manuel ^d   Villena, Victoria ^e   Blanquer, Rafael ^f   Montero, Carmen ^g   Sueiro, Antonio ^h   Disdier, Carlos ⁱ   Vendrell, Montserrat ^j  

^a HOSPITAL CLÍNIC   (Spain)

^b HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^e HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^f HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^g HOSPITAL JUAN CANALEJO   (Spain)

^h HOSPITAL RAMÓN Y CAJAL   (Spain)

ⁱ HOSPITAL SAN PEDRO DE ALCÁNTARA   (Spain)

^j HOSPITAL JOSEP TRUETA   (Spain)

more..

Author keywords

Epidemiology; Idiopathic interstitial pneumonias; Idiopathic pulmonary fibrosis; Interstitial lung diseases; Registration

Indexed keywords

ADULT; AGE; ALLERGIC PNEUMONITIS; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; DISEASE CLASSIFICATION; FEMALE; HUMAN; IDIOPATHIC DISEASE; INCIDENCE; INTERSTITIAL LUNG DISEASE; LUNG BIOPSY; LUNG FIBROSIS; LUNG LAVAGE; LUNG SARCOIDOSIS; MAJOR CLINICAL STUDY; MALE; ORGANIZING PNEUMONIA; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; REGISTER; SEX RATIO; SPAIN; TRANSBRONCHIAL BIOPSY; VASCULAR DISEASE;

AGED; EPIDEMIOLOGIC STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; REFERENCE VALUES; REGISTRIES; SPAIN;

EID: 11144355156     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Schwarz MI: Approach to the understanding, diagnosis and management of interstitial lung disease. In: Schwarz MI, King TE, eds. Interstitial lung disease. (B.C. Decker, Hamilton 1998); 3-30.
2. U.S. Department of Health, Education, and Welfare, Respiratory Diseases Task Force: Report on problems, research, approaches and needs. Washington, DC: U.S. Government Printing Office; 1972, 1976 (October 1976). DHEW Publication No. NIH 76-432.
3. Coultas DB, Zumwalt RE, Black WC, Sobonya RE: The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med 1994; 150: 967-72.
4. Roelandt M, Demedts M, Callebaut W, et al: Working group on ILD. Epidemiology of interstitial lung diseases in Flanders registration by pneumologists in 1992-1994. Acta Clin Belg 1995; 50: 260-8.
5. Thomeer M, Demetds M, Vandeurzen K and the VRGT working group on Interstitial Lung Diseases: Registration of interstitial lung diseases in 20 centers of respiratory medicine in Flanders. Acta Clin Belg 2001; 56: 163-72.
6. Schweisfurth H: Mitteilung der wissenschaftliches Arbeitsgemeinschaft für die Therapie Lungenkrankheiten (WATL): Deutsches Fibrosereregister mit ernsten Ergebnissen. Pneumologie 1996; 50: 899-901.
7. Agostini C, Albera C, Bariffi F, et al: First report of the Italian register for diffuse lung disorders. Monaldi Arch Chest Dis 2001; 56: 364-8.
8. Thomeer MJ, Costabel U, Rizzato G, Poletti V, Demedts M: Comparison of registries of interstitial lung diseases in three European countries. Eur Respir J 2001; 18: Suppl. 32, 114s-18s.
9. Idiopathic pulmonary fibrosis: diagnosis and treatment. Am J Respir Crit Care Med 2000; 161: 646-64.
10. American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2002; 165: 277-304.
11. Hubbard R, Lewis S, Richards K, Johnston I, Britton J: Occupational exposure to metal or wood dust and etiology of cryptogenic fibrosing alveolitis. Lancet 1996; 347: 284-9.
12. Hodgson U, Laitinen T, Tukiainen P: Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland. Thorax 2002; 57: 338-42.
13. Bjoraker JA, Ryu JH, Edwin MK, et al: Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998; 157: 199-203.
14. Nicholson AG, Colby TV, du Bois RM, Hansell DM, Wells AU: The prognostic significance of the histological pattern of idiopathic pneumonias in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 2000; 162: 2213-17.
15. Nagai S, Kitaichi M, Itoh H, Nishimura K, Izumi T, Colby TV: Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP. Eur Respir J 1998; 12: 1010-19.
16. Travis WD, Matsui K, Moss J, Ferrans VJ: Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing pattems-survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am J Surg Pathol 2000; 24: 19-33.
17. Flaherty KR, Travis WD, Colby TV, et al: Histopathological variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med 2001; 164: 1722-7.
18. Hartman TE, Swensen SJ, Hansell DM, et al: Nonspecific interstitial pneumonia: variable appearance at high-resolution chest CT. Radiology 2000; 217: 701-5.
19. Bresnitz EA, Strom BL: Epidemiology of sarcoidosis. Epidemiol Rev 1983; 5: 124-56.
20. Morera J, Aranda A, Badrinas F: Sarcoidosis in Spain. In: Chretien J, Marsac L, Saltiel JC, eds. Sarcoidosis and Other Granulomatous Disorders. Ninth International Conference. Pergamon Press, Paris, 1983; 625.
21. Kim DS: Sarcoidosis in Korea: report of the second nationwide survey. Sarcoidosis Vasc Diffuse Lung Dis 2001; 18: 176-80.
22. Byg KF, Milman N, Hansen S: Sarcoidosis in Denmark 1980-1994. A registry-based incidence study comprising 5536 patients. Sarcoidosis Vasc Diffuse Lung Dis 2003, 20: 46-52.
23. Nicholson AG, Colby TV, Wells AU: Histopathological approach to patterns of interstitial pneumonia in patients with connective tissue disorders. Sarcoidosis Vasc Diffuse Lung Dis 2002; 19: 10-17.
24. Bouros D, Wells AU, Nicholson AG, et al: Histopathological subsets of fibrosing alveolitis in patients with systemic sclerosis and their relation to outcome. Am J Respir Crit Care Med 2002; 165: 1581-6.
25. Douglas WW, Tazelaar D, Hartman TE, et al: Polymyositis-Dermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med 2001; 164: 1182-5.
26. Kim DS, Yoo B, Lee JS, et al: The major histopathologic pattern of pulmonary fibrosis in scleroderma is non-specific interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis 2002; 19: 121-7.
27. Bourke SJ, Dalphin JC, Boyd G, McSharry C, Baldwin CI, Calvert JE: Hypersensitivity pneumonitis: current concepts. Eur Respir J 2001; 18: Suppl. 32: 81s-92s.
28. The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults. British Thoracic Society Recommendations. Thorax 1999; 54, Supl. 1: S1-S30.
29. Delobbe A, Perrault H, Maitre J, et al: Impaired exercise response in sarcoid patients with normal pulmonary function. Sarcoidosis Vasc Diffuse Lung Dis 2002; 19: 148-53.
30. Xaubet A, Agusti C, Luburich P, et al: Pulmonary function tests and CT scan in the management of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998; 158: 431-6.
31. Chetta A, Aiello M, Foresi A, et al: Relationship between outcome measures of six-minute walk test and baseline lung function in patients with interstitial lung disease. Sarcoidosis Vasc Diffuse Lung Dis 2001; 18: 170-5.